Related Experiment Videos
Osteoporosis: The dynamic relationship between magnesium and bone mineral density in the heart transplant patient
Beatrice K Launius1, Patricia A Brown, Eleanor M Cush
1Department of Surgery, Louisiana State University Health Sciences Center, Shreveport, La, USA. blaunius@wkhs.com
Insights
Heart transplant recipients often develop osteoporosis due to pre-existing bone loss and post-transplant factors like corticosteroid use. This study investigates the link between serum magnesium levels and bone mineral density maintenance in these patients.
Area of Science:
- Nephrology
- Endocrinology
- Immunology
Background:
- Osteoporosis is a frequent and severe complication in heart transplant recipients.
- Bone mineral density loss often precedes transplantation, leading to fractures.
- Post-transplant osteoporosis is multifactorial, involving pre-transplant bone loss, immunosuppressive medications, and hypomagnesemia.
Purpose of the Study:
- To explore the relationship between serum magnesium levels and bone mineral density maintenance in heart transplant recipients.
- To identify key factors contributing to osteoporosis post-heart transplantation.
Main Methods:
- Review of literature on osteoporosis in heart transplant recipients.
- Analysis of factors contributing to bone mineral density loss.
- Exploration of the role of hypomagnesemia and serum magnesium levels.
Main Results:
- Pre-transplant bone mineral density loss is a significant factor.
- Corticosteroids and cyclosporine contribute to post-transplant bone loss.
- Persistent hypomagnesemia is implicated in the development of osteoporosis.
Conclusions:
- Serum magnesium levels are crucial for maintaining bone mineral density in heart transplant patients.
- Addressing hypomagnesemia may be a therapeutic target for preventing osteoporosis post-transplant.
- Further research is needed to elucidate the precise mechanisms linking magnesium and bone health in this population.
Abstract:
Osteoporosis is a common, and potentially severe, complication seen in the heart transplant recipient. Frequently there is loss of bone mineral density prior to transplant that begins the downward spiral to fractures of the femoral neck and vertebrae. Multiple factors are responsible for the development of osteoporosis posttransplant. These factors include pretransplant bone mineral loss, use of corticosteroids and cyclosporine posttransplant, and development of persistent hypomagnesemia posttransplant. This article explores the relationship of serum magnesium levels to maintenance of bone mineral density.
Related Concept Videos
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Skeleton and Calcium Homeostasis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
The Bone Matrix
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...